STOCK TITAN

argenx Announces Annual General Meeting of Shareholders on May 2, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

argenx SE (Euronext & Nasdaq: ARGX) announced its Annual General Meeting of shareholders to be held on May 2, 2023, at Hilton Amsterdam Schiphol. The agenda includes the adoption of annual accounts for 2022, an advisory vote on the 2022 remuneration report, and proposals for director reappointments and external auditor appointments. Shareholders will also review the renewal of the Board's authority to issue shares. The annual report for the financial year ending December 31, 2022, is now available on the company's website. All relevant documents can be accessed there, and shareholders are encouraged to vote by proxy.

Positive
  • Scheduled Annual General Meeting on May 2, 2023, providing shareholders with insights on company performance.
  • Availability of the annual report for 2022, promoting transparency.
  • Proposals to re-appoint board members and appoint external auditors suggest stability.
Negative
  • None.


March 17, 2023

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that an Annual General Meeting of shareholders will be held at 12:00 PM CET on Tuesday, May 2, 2023 at Hilton Amsterdam Schiphol at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.

The shareholders and all other persons with meeting rights are invited to attend the Annual General Meeting of shareholders. The formal notice of convocation (including information on attending the meeting in person or by proxy, requirements for notification and registration for the meeting and regarding the e-voting system) is available on the argenx website www.argenx.com and on www.abnamro.com/evoting.

The company’s annual report for the financial year ended December 31, 2022 is now available on its website www.argenx.com/investors/financial-reports.

Agenda
The agenda includes the discussion and adoption of the annual accounts for the 2022 financial year, an advisory vote on the company’s 2022 remuneration report, the discharge of the directors for their duties performed in 2022, the proposal to re-appoint Mr. Don deBethizy to the Board of Directors for a period of two years, renewal of the authorization of the Board of Directors to issue shares and to limit or exclude pre-emptive rights in relation thereto, the proposal to appoint Deloitte Accountants B.V. as the company’s external auditor for the 2023 financial year.

The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available via the argenx website and are also available for inspection at the argenx offices. A free copy thereof may also be obtained by e-mailing legal@argenx.com. argenx would like to encourage shareholders to use the voting by (electronic) proxy option as referred to in the convocation.

About argenx 
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan, the EU and the UK. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedInTwitter, and Instagram

For further information, please contact:  

Media:
Erin Murphy
emurphy@argenx.com

Investors:
Beth DelGiacco
bdelgiacco@argenx.com


FAQ

When is the argenx Annual General Meeting in 2023?

The argenx Annual General Meeting is scheduled for May 2, 2023, at 12:00 PM CET.

What is on the agenda for the argenx Annual General Meeting?

The agenda includes discussions on the 2022 annual accounts, remuneration report, board member reappointments, and external auditor proposals.

Where will the argenx Annual General Meeting take place?

The meeting will be held at Hilton Amsterdam Schiphol, located at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.

How can shareholders vote at the argenx Annual General Meeting?

Shareholders can attend in person or vote by proxy through electronic means as outlined in the meeting's formal notice.

Where can I find argenx's annual report for 2022?

The annual report for the financial year ending December 31, 2022, can be found on argenx's website under the investors' section.

argenx SE American Depositary Shares

NASDAQ:ARGX

ARGX Rankings

ARGX Latest News

ARGX Stock Data

37.14B
59.47M
0%
59.76%
3.47%
Biotechnology
Healthcare
Link
United States of America
Amsterdam